Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04268498 |
Title | A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Memorial Sloan Kettering Cancer Center |
Indications | |
Therapies |
Carfilzomib + Dexamethasone + Lenalidomide |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Miami | Recruiting | Miami | Florida | 33136 | United States | Details |
Moffitt Cancer Center | Not yet recruiting | Tampa | Florida | 33612-9497 | United States | Details |
Rush University Medical Center | Not yet recruiting | Chicago | Illinois | 606012 | United States | Details |
Roswell Park Comprehensive Cancer Center | Not yet recruiting | Buffalo | New York | 14203 | United States | Details |
Memorial Sloan Kettering Cancer Center | Recruiting | New York | New York | 10065 | United States | Details |
Stony Brook University | Not yet recruiting | Stony Brook | New York | 11794 | United States | Details |
MD Anderson Cancer Center | Not yet recruiting | Houston | Texas | 77030 | United States | Details |
Huntsman Cancer Institue | Not yet recruiting | Salt Lake City | Utah | 84113 | United States | Details |
Skåne University Hospital | Not yet recruiting | Malmö | 9, 214 | Sweden | Details |